PACTR201209000394102招募中未知
Observation of Early Bactericidal Activity of Standard Tuberculosis Treatment
Dr. Norbert Heinrich, Department fo Infectious Diseaes and Tropical Medicine, Klinium University of Munich (LMU)0 个研究点目标入组 140 人开始时间: 2012年6月21日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 140
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 Year(s) 至 65 Year(s)（—）
- 性别
- All
入选标准
- •Provide informed consent (written or oral witnessed for illiterate patients) prior to all study-related procedures including HIV testing.
- •Male and female patients of 18-65 years, weight range 31-90 kg
- •Positive sputum smear for AFB bacilli (at least 1+ on the IUATLD/WHO scale).
- •Ability to produce an adequate volume and quality of sputum as estimated from a spot assessment (estimated 10 mL or more overnight production).
- •Karnofsky Score of at least 60 (requires occasional assistance but is able to care for most of his/her needs)
- •Pre-menopausal women must have a negative pregnancy test and consent to an effective method of contraception, which includes at least one barrier method.
- •If on Highly Active Antiretroviral Treatment (HAART), written confirmation of HAART compatibility with HRZE TB treatment from the treating physician is necessary.
排除标准
- •Poor general condition interfering with sputum production, warranting intensive care or with high likelihood of death before completion of study
- •Patients for whom the study-inherent delay of at least two days for TB treatment initiation poses a significant risk
- •Central nervous system TB or miliary TB.
- •Drug resistance in the screening isolate (Rifampicin resistance) detected with a fast molecular assay on the screening sputum.
- •Treatment received with drugs active against M. tuberculosis for more than 7 days within the last 2 months prior to Visit P3.
- •This includes the standard TB drugs HRZE, second-line TB drugs like amikacin, cycloserine, rifabutin, rifapentine, gentamicin, streptomycin, kanamycin, para-aminosalicylic acid, thioacetazone, capreomycin, quinolones, thioamides.
- •Contraindications to study drugs including standard TB treatment, such as a history of allergy, significant liver and/or kidney function abnormalities, e.g. AST or ALT elevated to >3x upper limit of normal, bilirubin of > 2x upper limit of normal, creatinine of >2x upper limit of normal on screening laboratory, which may be taken up to 7 days before visit P1 in the study site laboratory.
- •Evidence of serious lung conditions other than TB.
- •History and/or presence (or evidence) of optical neuritis.
- •Diabetics using insulin.
- •Evidence of clinically significant abnormalities which may interfere with TB and treatment according to the Investigator`s judgement, e.g. in metabolic, gastrointestinal, neurological, psychiatric or endocrine area as well as malignancy,
- •Known or suspected alcohol or drug abuse which is judged to compromise the safety or cooperation of the patient. For recreational drug abuse, investigators may use some discretion in determining whether a patient should be excluded on this basis alone.
- •Administration of an Investigational Medicinal Product within 1 month prior to Visit 1.
- •Breast feeding or other circumstances with need for hospi
研究者
相似试验
进行中（未招募）
1 期
Evaluation of the Early Bactericidal Activity of Tedizolid and Linezolide Against Mycobacterium Tuberculosis (TEDITUB)first suspected infection with Mycobacterium tuberculosis in the lungsMedDRA version: 20.0Level: SOCClassification code: 10021881Term: Infections and infestations Class: 1MedDRA version: 20.1Level: LLTClassification code: 10070578Term: Multidrug resistant tuberculosis Class: 10021881CTIS2024-512759-19-00Assistance Publique Hopitaux De Paris60
已完成
4 期
Determination of the Antibacterial Effect of Biodentine in vivo - Identification of Polybacterial 16S rRNA Genes in Caries Samples by T-RFLP and Direct SequencingK02Dental cariesDRKS00011067Septodont10
已完成
不适用
Determination of the Antibacterial effect of Clearfil Protect Bond in-vivo – Identification of Polybacterial 16S rRNA genes in caries samples by T-RFLP and direct sequencingK02.1K02.9Caries of dentineDental caries, unspecifiedDRKS00011532niversitätsklinikum Leipzig10
尚未招募
不适用
Assessment of the antimicrobial activity of the antibacterial peptide fiberinfection contorolJPRN-UMIN000013255Wakayama Medical University Hospital Department of Infection control20
招募中
不适用
antimicrobials in appendicitisacute appendicitisoperative and non operative managementpossible microorganisms for acute appendicitisPerforated Appendicitissimple, gangrenous, or perforated appendicitisMicrobial Sensitivity TestsAppendicitisTCTR20211222004Faculty of Medicine for Girls (Cairo) Research Ethics Committee- RHBIRB2018122001100